{
    "nctId": "NCT03572361",
    "briefTitle": "Open Label Immunotherapy Trial for Breast Cancer",
    "officialTitle": "Open Label, One-arm, 3-month Study of Once-daily Tablet of V3-MOMMO as Immunotherapy of Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Effect on tumor size",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Confirmed diagnosis of breast cancer positive at least for CEA tumor marker at above normal threshold level\n\nExclusion Criteria:\n\n* Mastectomy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}